Robert Tarr, Dan Hsu, Zsolt Kulcsar, Christophe Bonvin, Daniel Rufenacht, Karsten Alfke, Robert Stingele, Olav Jansen, Donald Frei, Richard Bellon, Michael Madison, Tobias Struffert, Arnd Dorfler, Iris Q Grunwald, Wolfgang Reith, Anton Haass
BACKGROUND AND PURPOSE: The purpose of this study was to assess the initial post-market experience of the device and how it is compared with the Penumbra Pivotal trial used to support the 510k application. METHODS: A retrospective case review of 157 consecutive patients treated with the Penumbra system at seven international centers was performed. Primary endpoints were revascularization of the target vessel (TIMI score of 2 or 3), good functional outcome as defined by a modified Rankin scale (mRS) score of ≤2 and incidence of procedural serious adverse events...
December 2010: Journal of Neurointerventional Surgery